TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/23 18:01 | 12/14/23 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Klencke Barbara | MA | D | P | 25 | 5.08 | 0 | 5 | 10 | 55 | D | |||||||||||||||
8/18/20 20:16 | 8/18/20 | SRRA | Sierra Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klencke Barbara | A1 | O | Chief De | P | 113 | 12.23 | 0 | 9 | 162 | 15 | M | ||||||||||||||
8/26/19 17:07 | 8/22/19 | SRRA | Sierra Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klencke Barbara | A1 | O | Chief De | P.m | 101 | 0.4395 | 0 | 229 | New | 229 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |